[1] 侯月盈,段新旺,李芹,等.不同性别系统性硬化症患者的临床特点分析[J].中华内科杂志,2022,61(4):403-408.
[2] Elhai M,Meune C,Boubaya M,et al.Mapping and predicting mortality from systemic sclerosis[J]. Ann Rheum Dis,2017,76(11):1897-1905.
[3] 李小芬,韦夙,王乐,等.系统性硬化症的主要发病因素及治疗研究进展[J].药物生物技术,2020,27(4):390-392.
[4] 颜真波,卢小平,陈雅硕.系统性硬化症的临床特征及研究进展[J].风湿病与关节炎,2023,12(11):66-70.
[5] 邹和建,朱小霞,戴生明,等.系统性硬化病诊疗规范[J].中华内科杂志,2022,61(8):874-882.
[6] Gyger G,Baron M.Systemic sclerosis: gastrointestinal disease and its management[J].Rheum Dis Clin North Am,2015,41(3):459-473.
[7] Jerjen R,Nikpour M,Krieg T,et al. Systemic sclerosis in adults. Part Ⅰ:clinical features and pathogenesis[J].J Am Acad Dermatol,2022,87(5):937-954.
[8] 邹松炎,张日伊,李孝东,等.系统性硬化症合并干燥综合征的临床和实验室特点分析及危险因素研究[J].中国全科医学,2025,28(6):737-741.
[9] Han H S,Ahn G R,Kim H J,et al.Diffuse systemic sclerosis in a patient with primary biliary cirrhosis and autoimmune hepatitis overlap syndrome:a case report[J].Ann Dermatol,2020,32(1):69-73.
[10] D'Angelo W A,Fries J F,Masi A T,et al.Pathologic observationsin systemic sclerosis (scleroderma).A study of fifty-eight autopsy cases and fifty-eight matched controls[J].Am J Med,1969,46(3):428-440.
[11] Takagi K,Nishio S,Akimoto K,et al.A case of systemic sclerosis complicated by idiopathic portal hypertension:case report and literature review[J].Mod Rhe-umatol,2006,16:183-187.
[12] Graf L,Dobrota R,Jordan S,et al.Nodular regenerative hyperplasia of the liver: a rare vascular complication in systemic sclerosis[J].J Rheumatol,2018,45:103-106.
[13] Youssef W I,Tavill A S.Connective tissue diseases and the liver[J]. J Clin Gastroenterol,2002,35:345-349. |
